Skip to content
Dx

HCPCS Level II · Procedures and professional services (temporary)

G0533Medication assisted treatment, buprenorphine (injectable) administered on a weekly basis; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)

✓ Active

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About G0533

G0533 is an HCPCS Level II code in the G series (procedures and professional services (temporary)), describing medication assisted treatment, buprenorphine (injectable) administered on a weekly basis; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program).

It was added to HCPCS effective 01/01/2025.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
Buprenorphone inj weekly
Date added
01/01/2025
Action effective
01/01/2025
BETOS
M5D

Related G05xx codes

Common questions about G0533

Is HCPCS G0533 still valid?

Yes. G0533 is active in the CMS October 2026 HCPCS file.

Does Medicare cover G0533?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.